查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1672435

2025年全球介入性腫瘤設備市場報告

Interventional Oncology Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年介入腫瘤設備市場規模將強勁成長。到 2029 年，這一數字將成長至 33.4 億美元，年複合成長率（CAGR）為 7.3%。預測期內的成長可歸因於老年人口的增加、對微創手術（MIS）的偏好日益成長、研發支出的增加、醫療保健支出的增加、新興經濟體的巨大潛力以及癌症和慢性病患病率的增加。預測期內的關鍵趨勢包括專注於開發先進的影像引導腫瘤學設備、利用人工智慧開發創新設備、開發能夠改善腫瘤學程式的新型創新栓塞設備、專注於利用機器人技術以及與其他公司和研究機構合作以加速產品開發和創新。

介入腫瘤設備市場的主要企業正專注於組織體積等技術進步，以提高癌症治療的診斷準確性和治療效果。組織體積是切片檢查過程中所獲得的生物組織量。收集的組織樣本越多，分析就越徹底，從而可以做出更準確的診斷並更容易制定治療計劃。例如，2023年6月，美國醫療設備製造商Argon Medical宣布推出SuperCore Advantage半自動切片檢查設備。 SuperCore Advantage 比競爭產品多提取 35% 的組織，減少了多次切片檢查的需要，而多次活體組織切片對於獲取足夠的組織進行準確診斷至關重要。

癌症高發生率預計將推動介入腫瘤設備市場的成長。癌症是一組以細胞生長不受控制為特徵的疾病，導致腫塊或腫瘤的形成。這種高盛行率產生了對介入性腫瘤設備的需求，這些設備對於癌症的診斷、治療和管理至關重要，可以實現早期發現、分期和監測。例如，2024年7月，澳洲健康與福利研究所報告稱，澳洲癌症診斷數量從2022年的160,570例增加到2023年的164,694例，與前一年同期比較呈現顯著成長。這一趨勢導致癌症發生率不斷上升，從而支持了市場對介入性腫瘤設備的需求。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球介入性腫瘤設備PESTEL分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球介入性腫瘤設備市場：成長率分析
  • 全球介入性腫瘤設備市場表現：規模與成長，2019-2024
  • 全球介入性腫瘤器材市場預測：規模與成長，2024-2029，2034F
  • 介入性腫瘤器材的全球總目標市場（TAM）

第6章市場區隔

  • 全球介入性腫瘤設備市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 栓塞裝置
  • 消融裝置
  • 支援的設備
  • 全球介入性腫瘤器材市場（按流程、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 腫瘤熱消融
  • 非熱腫瘤消融
  • 經導管動脈化療栓塞術（TACE）
  • 經導管動脈栓塞術（TARE）
  • 選擇性體內放射療法(SIRT)
  • 經導管動脈栓塞術（TAE）
  • 溫和栓塞
  • 全球介入性腫瘤器材市場（依癌症類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 肝癌
  • 腎癌
  • 肺癌
  • 骨癌
  • 其他類型的癌症
  • 全球介入性腫瘤設備市場，按栓塞設備類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 栓塞劑
  • 栓塞導管
  • 栓塞劑輸送系統
  • 全球介入性腫瘤設備市場消融設備細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 射頻消融術裝置
  • 微波消融裝置
  • 冷凍消融裝置
  • 雷射消熔設備
  • 全球介入性腫瘤設備市場，按支援設備細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 影像引導系統
  • 存取裝置
  • 流體管理系統

第7章 區域和國家分析

  • 全球介入性腫瘤設備市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球介入性腫瘤設備市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 介入性腫瘤設備市場：競爭格局
  • 介入性腫瘤設備市場：公司簡介
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • Henlius Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Viant Medical
  • AngioDynamics Inc.
  • Pfizer
  • Steris Applied Sterilization Technologies
  • Dr.Reddys
  • CapeRay
  • Innovent Biologics
  • Novartis AG
  • Consonance
  • ABLbio
  • Adimmune
  • Heraeus Medical
  • Bioavlee
  • Mediceena International
  • Sinapi biomedical

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年介入腫瘤設備市場：提供新機會的國家
  • 2029年介入性腫瘤器材市場：細分市場將帶來新機會
  • 2029年介入性腫瘤設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r25727

Interventional oncology devices are specialized medical tools and technologies designed for the minimally invasive diagnosis and treatment of cancer. These devices enable direct targeting of tumors, allowing for treatments such as ablation or embolization, which focus on destroying cancer cells while preserving nearby healthy tissue.

The primary products within the field of interventional oncology devices include embolization devices, ablation devices, and support devices. Embolization devices are designed for the embolization of blood vessels associated with various tumors. These devices are employed in procedures such as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE), selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. These procedures are applied in the treatment of various cancer types, including liver cancer, kidney cancer, lung cancer, bone cancer, and others.

The interventional oncology devices market research report is one of a series of new reports from The Business Research Company that provides interventional oncology devices market statistics, including interventional oncology devices industry global market size, regional shares, competitors with a interventional oncology devices market share, detailed interventional oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the interventional oncology devices industry. This interventional oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional oncology devices market size has grown strongly in recent years. It will grow from $2.39 billion in 2024 to $2.52 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to aging population pool, an increase in cancer prevalence, increase in pharmaceutical R&D expenditure, increased healthcare expenditure and growth in the number of healthcare facilities.

The interventional oncology devices market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing older population, increasing preference towards minimally invasive surgeries (MIS), increasing research and development spending, a rise in healthcare expenditure, high potential in emerging economies and increasing prevalence of cancer and chronic diseases. Major trends in the forecast period include focusing on developing advanced image-guided oncology devices, utilizing ai to develop innovative devices, developing new, innovative embolic devices to enable improved oncology procedures, focusing on using robotics technology and collaborating with other companies and research institutes to accelerate product development and innovation.

Leading companies in the interventional oncology devices market are focusing on advancements in technologies, such as tissue volume, to improve diagnostic accuracy and treatment efficacy in cancer procedures. Tissue volume refers to the quantity of biological tissue obtained during a biopsy. Collecting larger tissue samples allows for more thorough analysis, enhancing diagnostic precision and aiding in effective treatment planning. For example, in June 2023, Argon Medical, a U.S.-based medical device company, introduced the SuperCore Advantage semi-automatic biopsy device. The SuperCore Advantage collects up to 35% more tissue than competing products, reducing the need for multiple biopsy passes, which is essential for acquiring sufficient tissue for accurate diagnosis.

The high prevalence of cancer is expected to drive the growth of the interventional oncology devices market. Cancer is a group of diseases characterized by uncontrolled cell growth, leading to the formation of masses or tumors. This high prevalence creates a demand for interventional oncology devices, essential for diagnosing, treating, and managing cancer, enabling early detection, staging, and monitoring. For instance, in July 2024, the Australian Institute of Health and Welfare reported an increase in cancer diagnoses in Australia from 160,570 cases in 2022 to 164,694 in 2023, marking a significant year-over-year rise. This trend underscores the growing cancer prevalence, supporting the demand for interventional oncology devices in the market.

Companies in the interventional oncology devices market are increasingly incorporating robotics technology to enhance efficiency. Robotic systems integrate image-based planning and navigation, allowing accurate and efficient installation of instruments to specific body parts. In March 2022, the U.S. Food and Drug Administration approved Quantum Surgical's Epione interventional oncology robotics platform, showcasing the industry's commitment to technological advancements.

Major players in the interventional oncology devices market are focused on innovation, such as AI-powered digital pathology solutions, to enhance the accuracy of breast cancer diagnosis. Paige AI Inc., a U.S.-based biotechnology company, launched Paige Breast Lymph Node in March 2022, an AI-powered digital pathology solution improving the detection of breast cancer metastases in lymph node tissue. This technology offers AI-driven detection capabilities, a convenient heat map overlay, high sensitivity and specificity, seamless integration into existing workflows, user-friendliness, and robust security measures.

In August 2022, Boston Scientific Corporation acquired Obsidio Inc. for an undisclosed amount, aiming to expand its interventional oncology portfolio and strengthen its position in the growing market. Obsidio Inc., a U.S.-based medical device company, specializes in developing minimally invasive interventional oncology devices for treating liver cancer and other solid tumors.

Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the interventional oncology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The interventional oncology devices market consists of sales of embolization devices, ablation devices, and support devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Oncology Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional oncology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional oncology devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Embolization Devices, Ablation Devices, Support Devices
  • 2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
  • 3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
  • Subsegments:
  • 1) By Embolization Devices: Embolic Agents; Catheters For Embolization; Delivery Systems For Embolic Agents
  • 2) By Ablation Devices: Radiofrequency Ablation Devices; Microwave Ablation Devices; Cryoablation Devices; Laser Ablation Devices
  • 3) By Support Devices: Imaging Guidance Systems; Access Devices; Fluid Management Systems
  • Companies Mentioned: Boston Scientific Corporation; Terumo Corporation; Siemens Healthineers; Sirtex Medical Limited; Henlius
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Oncology Devices Market Characteristics

3. Interventional Oncology Devices Market Trends And Strategies

4. Interventional Oncology Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Interventional Oncology Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interventional Oncology Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interventional Oncology Devices Market Growth Rate Analysis
  • 5.4. Global Interventional Oncology Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interventional Oncology Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interventional Oncology Devices Total Addressable Market (TAM)

6. Interventional Oncology Devices Market Segmentation

  • 6.1. Global Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embolization Devices
  • Ablation Devices
  • Support Devices
  • 6.2. Global Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Thermal Tumor Ablation
  • Non-thermal Tumor Ablation
  • Transcatheter Arterial Chemoembolization (TACE)
  • Transcatheter Arterial Radioembolization (TARE)
  • Selective Internal Radiation Therapy (SIRT)
  • Transcatheter Arterial Embolization (TAE)
  • Bland Embolization
  • 6.3. Global Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Bone Cancer
  • Other Cancer Types
  • 6.4. Global Interventional Oncology Devices Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embolic Agents
  • Catheters For Embolization
  • Delivery Systems For Embolic Agents
  • 6.5. Global Interventional Oncology Devices Market, Sub-Segmentation Of Ablation Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Laser Ablation Devices
  • 6.6. Global Interventional Oncology Devices Market, Sub-Segmentation Of Support Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Imaging Guidance Systems
  • Access Devices
  • Fluid Management Systems

7. Interventional Oncology Devices Market Regional And Country Analysis

  • 7.1. Global Interventional Oncology Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interventional Oncology Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Oncology Devices Market

  • 8.1. Asia-Pacific Interventional Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Oncology Devices Market

  • 9.1. China Interventional Oncology Devices Market Overview
  • 9.2. China Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Oncology Devices Market

  • 10.1. India Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Oncology Devices Market

  • 11.1. Japan Interventional Oncology Devices Market Overview
  • 11.2. Japan Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Oncology Devices Market

  • 12.1. Australia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Oncology Devices Market

  • 13.1. Indonesia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Oncology Devices Market

  • 14.1. South Korea Interventional Oncology Devices Market Overview
  • 14.2. South Korea Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Oncology Devices Market

  • 15.1. Western Europe Interventional Oncology Devices Market Overview
  • 15.2. Western Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Oncology Devices Market

  • 16.1. UK Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Oncology Devices Market

  • 17.1. Germany Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Oncology Devices Market

  • 18.1. France Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Oncology Devices Market

  • 19.1. Italy Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Oncology Devices Market

  • 20.1. Spain Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Oncology Devices Market

  • 21.1. Eastern Europe Interventional Oncology Devices Market Overview
  • 21.2. Eastern Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Oncology Devices Market

  • 22.1. Russia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Oncology Devices Market

  • 23.1. North America Interventional Oncology Devices Market Overview
  • 23.2. North America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Oncology Devices Market

  • 24.1. USA Interventional Oncology Devices Market Overview
  • 24.2. USA Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Oncology Devices Market

  • 25.1. Canada Interventional Oncology Devices Market Overview
  • 25.2. Canada Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Oncology Devices Market

  • 26.1. South America Interventional Oncology Devices Market Overview
  • 26.2. South America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Oncology Devices Market

  • 27.1. Brazil Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Oncology Devices Market

  • 28.1. Middle East Interventional Oncology Devices Market Overview
  • 28.2. Middle East Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Oncology Devices Market

  • 29.1. Africa Interventional Oncology Devices Market Overview
  • 29.2. Africa Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Oncology Devices Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Oncology Devices Market Competitive Landscape
  • 30.2. Interventional Oncology Devices Market Company Profiles
    • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Henlius Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Oncology Devices Market Other Major And Innovative Companies

  • 31.1. Viant Medical
  • 31.2. AngioDynamics Inc.
  • 31.3. Pfizer
  • 31.4. Steris Applied Sterilization Technologies
  • 31.5. Dr.Reddys
  • 31.6. CapeRay
  • 31.7. Innovent Biologics
  • 31.8. Novartis AG
  • 31.9. Consonance
  • 31.10. ABLbio
  • 31.11. Adimmune
  • 31.12. Heraeus Medical
  • 31.13. Bioavlee
  • 31.14. Mediceena International
  • 31.15. Sinapi biomedical

32. Global Interventional Oncology Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Oncology Devices Market

34. Recent Developments In The Interventional Oncology Devices Market

35. Interventional Oncology Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Interventional Oncology Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interventional Oncology Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interventional Oncology Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer